BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30683688)

  • 21. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
    Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
    Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
    Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
    Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.
    Schadt L; Sparano C; Schweiger NA; Silina K; Cecconi V; Lucchiari G; Yagita H; Guggisberg E; Saba S; Nascakova Z; Barchet W; van den Broek M
    Cell Rep; 2019 Oct; 29(5):1236-1248.e7. PubMed ID: 31665636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
    Sibal PA; Matsumura S; Ichinose T; Bustos-Villalobos I; Morimoto D; Eissa IR; Abdelmoneim M; Aboalela MAM; Mukoyama N; Tanaka M; Naoe Y; Kasuya H
    Mol Oncol; 2024 May; 18(5):1259-1277. PubMed ID: 38400597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive feedback regulation of type I interferon by the interferon-stimulated gene STING.
    Ma F; Li B; Yu Y; Iyer SS; Sun M; Cheng G
    EMBO Rep; 2015 Feb; 16(2):202-12. PubMed ID: 25572843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAVS-dependent IRF3/7 bypass of interferon β-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells.
    Takaki H; Honda K; Atarashi K; Kobayashi F; Ebihara T; Oshiumi H; Matsumoto M; Shingai M; Seya T
    Mol Immunol; 2014 Feb; 57(2):100-10. PubMed ID: 24096085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The STING in the tail for cytosolic DNA-dependent activation of IRF3.
    Bowie A
    Sci Signal; 2012 Mar; 5(214):pe9. PubMed ID: 22394560
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Costa Franco MM; Marim F; Guimarães ES; Assis NRG; Cerqueira DM; Alves-Silva J; Harms J; Splitter G; Smith J; Kanneganti TD; de Queiroz NMGP; Gutman D; Barber GN; Oliveira SC
    J Immunol; 2018 Jan; 200(2):607-622. PubMed ID: 29203515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel chemical compound SINCRO with dual function in STING-type I interferon and tumor cell death pathways.
    Kimura Y; Negishi H; Matsuda A; Endo N; Hangai S; Inoue A; Nishio J; Taniguchi T; Yanai H
    Cancer Sci; 2018 Sep; 109(9):2687-2696. PubMed ID: 29981256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism.
    Bai J; Liu F
    Diabetes; 2019 Jun; 68(6):1099-1108. PubMed ID: 31109939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
    Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
    Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells.
    Gutjahr A; Papagno L; Nicoli F; Kanuma T; Kuse N; Cabral-Piccin MP; Rochereau N; Gostick E; Lioux T; Perouzel E; Price DA; Takiguchi M; Verrier B; Yamamoto T; Paul S; Appay V
    JCI Insight; 2019 Apr; 4(7):. PubMed ID: 30944257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mTOR Complex Signaling through the SEMA4A-Plexin B2 Axis Is Required for Optimal Activation and Differentiation of CD8+ T Cells.
    Ito D; Nojima S; Nishide M; Okuno T; Takamatsu H; Kang S; Kimura T; Yoshida Y; Morimoto K; Maeda Y; Hosokawa T; Toyofuku T; Ohshima J; Kamimura D; Yamamoto M; Murakami M; Morii E; Rakugi H; Isaka Y; Kumanogoh A
    J Immunol; 2015 Aug; 195(3):934-43. PubMed ID: 26116513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of STING signaling accelerates skin wound healing.
    Mizutani Y; Kanbe A; Ito H; Seishima M
    J Dermatol Sci; 2020 Jan; 97(1):21-29. PubMed ID: 31813660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transfer of cGAMP into Bystander Cells via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity.
    Zhou C; Chen X; Planells-Cases R; Chu J; Wang L; Cao L; Li Z; López-Cayuqueo KI; Xie Y; Ye S; Wang X; Ullrich F; Ma S; Fang Y; Zhang X; Qian Z; Liang X; Cai SQ; Jiang Z; Zhou D; Leng Q; Xiao TS; Lan K; Yang J; Li H; Peng C; Qiu Z; Jentsch TJ; Xiao H
    Immunity; 2020 May; 52(5):767-781.e6. PubMed ID: 32277911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA.
    Kim J; Pena JV; McQueen HP; Kong L; Michael D; Lomashvili EM; Cook PR
    Cancer Gene Ther; 2024 Jan; 31(1):28-42. PubMed ID: 37990062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA.
    Wu J; Sun L; Chen X; Du F; Shi H; Chen C; Chen ZJ
    Science; 2013 Feb; 339(6121):826-30. PubMed ID: 23258412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.